Identity
- Security key
- 19587
- Ticker
- OGN
- Type
- CS — Common Stock
- Exchange
- New York Stock Exchange(XNYS)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-05-14
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- OGN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $3,587,244,854.78
- Shares outstanding (class)
- 262,609,433
- Shares outstanding (weighted)
- 262,609,433
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 10,000
- Location
- JERSEY CITY, NJ
- Homepage
- https://www.organon.com
- Description
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.